About POAI

Predictive Oncology Inc. is a data and artificial intelligence (AI)-driven discovery services company. The Company provides predictive models of tumor drug response that are used to improve clinical outcomes for patients. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment includes clinical testing and contract research services that include the application of AI. zPREDICTA specializes in organ-specific disease models that provide 3D reconstruction of human tissues, accurately representing each disease state and mimicking drug response, enabling accurate testing of anticancer agents. The Soluble segment provides services using a self-contained, automated system that conducts throughput, self-interaction chromatography screens using additives and excipients commonly included in protein formulations, resulting in soluble and physically stable formulations for biologics. The Skyline segment consists of the STREAMWAY System product sales.